When a disease spreads beyond borders and affects people across multiple countries or continents, the situation is described as a pandemic. This term signals a far-reaching, worldwide reach, not just a local or regional spike in cases. An epidemic, by contrast, refers to a surge in cases in a particular community or region that is above what’s normally expected. Zoonoses are diseases transmitted from animals to humans, and anthroponoses are diseases that are transmitted from person to person but can be limited to specific populations or regions. The key distinction is scale and geography: pandemic = global, epidemic = localized or regional.

Anthroponoses are diseases for which humans are the only known reservoir. A reservoir is the population in which a pathogen normally lives and multiplies; when only humans harbor it, the pathogen is maintained solely through human-to-human transmission, with no non-human hosts required. This makes control rely heavily on interrupting person-to-person spread, through vaccination, case finding, and isolation. Classic examples include measles, rubella, diphtheria, and poliomyelitis; smallpox is another historic case that has been eradicated. In contrast, epidemic or pandemic describes the size of an outbreak, not the reservoir. Zoonoses involve animal reservoirs, meaning non-human hosts are part of the pathogen’s life cycle.

Understanding the difference between incidence and prevalence starts with what each measure counts. Incidence looks at new cases that appear in a population during a defined time period, giving a sense of the rate at which people are developing the condition. Prevalence, on the other hand, counts all existing cases—both new and pre-existing—at a specific point in time (point prevalence) or over a defined period (period prevalence). So the correct statement is that incidence measures new cases over time, while prevalence measures all existing cases at a point or over a period. The other descriptions mix up what each rate counts—for example, incidence is not about all existing cases, and prevalence is not limited to only new cases.

The distinction being tested is that policy development relies on synthesized, rigorous evidence and economic analysis, while decision-making hinges on ongoing monitoring and practical evaluation. For policy development, you want broad, high-quality information that summarizes what works across multiple settings and weighs costs and benefits—think systematic reviews and cost-effectiveness analyses. This helps policymakers choose options with the best potential impact and value for money before adopting a policy at a population level. In contrast, decision-making focuses on data gathered during implementation: surveillance data track health trends and outcomes in the real world, program evaluations assess how well programs are working in practice, and community input brings local needs and preferences into the process. This combination supports adapting and refining decisions as conditions change. The other options misfit because they either rely on only a single data source, depend on anecdotes or opinions, or claim that both processes use the same data.